Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 65.89% | 35.86% | -16.67% | -114.61% | -70.21% |
| Total Depreciation and Amortization | -26.45% | 37.35% | 68.00% | -10.69% | -53.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.72% | -38.12% | 56.49% | 978.72% | 1,495.63% |
| Change in Net Operating Assets | 412.22% | 259.55% | 178.43% | 161.04% | 50.18% |
| Cash from Operations | 65.27% | 75.35% | 68.29% | 60.21% | 54.30% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 173,740.00% | -- | 107.94% | 106.41% | 106.41% |
| Total Debt Issued | -43.43% | -29.20% | -66.23% | -84.06% | -82.29% |
| Total Debt Repaid | 22.23% | -44.96% | -115.14% | -134.28% | -1,137.12% |
| Issuance of Common Stock | -97.85% | -78.21% | -78.21% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | 99.65% |
| Cash from Financing | -76.57% | -59.88% | -73.52% | -44.44% | -10.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 287.50% | 97.74% | -2,603.33% | 93.84% | 91.36% |